Our Services
Medical Information
Helpful Resources
Published on: 8/18/2026
Low alkaline phosphatase (ALP) can weaken bones because this enzyme is essential for mineralizing the skeleton, and without enough of it, calcium and phosphate fail to deposit properly into bone. Causes range from inherited hypophosphatasia to zinc or magnesium deficiency, malnutrition, hypothyroidism, celiac disease, and certain medications like bisphosphonates or steroids. Warning signs may include bone pain, frequent fractures, dental problems such as early tooth loss, muscle weakness, and in children, delayed growth or skeletal deformities. Doctor next steps typically involve repeat ALP testing, checking vitamin B6, calcium, phosphate, magnesium, and zinc levels, imaging for fractures or bone density loss, and possibly genetic testing for hypophosphatasia. Several factors influence severity and treatment, so see below to understand the full picture.
Not sure whether your bone pain, fractures, or low ALP results need urgent attention? A free, instant, online symptom check can help you organize your symptoms, spot patterns worth flagging, and clarify what to discuss with your doctor at your next visit.
Last reviewed for medical accuracy: 08/18/2026
Alkaline phosphatase (ALP) is an enzyme measured in blood tests to help evaluate liver and bone health. When ALP levels fall below the normal range—often reported as “alk phos u/l”—it can signal issues that impair bone mineralization and weaken skeletal strength. This guide explains why low ALP matters, what may cause it, and the next steps you and your doctor can take.
Bones rely on ALP for mineral deposition. When ALP is low:
Several factors can depress alk phos u/l values. Identifying the root cause guides treatment.
Low ALP itself doesn’t cause symptoms, but the underlying issue may present as:
If you notice any of these, it’s important to record your symptoms and discuss them with your healthcare provider.
When lab results show low alk phos u/l, your doctor may recommend:
Therapy targets the underlying cause of low ALP and aims to improve bone strength:
For a free, convenient way to track your symptoms and discuss concerns, consider a free, online symptom check, using the doctor approved Ubie Symptom Checker.
Contact a healthcare professional right away if you experience:
Always discuss lab results and any worrisome symptoms with your primary care provider or specialist.
Low alk phos u/l can hint at a spectrum of conditions, some of which affect bone health profoundly. By understanding the causes, pursuing targeted diagnostics, and working with your doctor on treatment strategies, you can support stronger bones and better overall health. If you have any life-threatening or serious concerns, please speak to a doctor immediately.
(References)
* Scriver CR, Cameron D. Pseudohypophosphatasia. N Engl J Med. 1969 Sep 11;281(11):604-6. doi: 10.1056/NEJM196909112811107. PMID: 4309618.
* Sucato GS. Bone density and contraception in adolescent girls. J Pediatr Adolesc Gynecol. 2004 Dec;17(6):371-2. doi: 10.1016/j.jpag.2004.09.005. PMID: 15603977.
* Drake MT, Khosla S. Bone-targeted replacement therapy for hypophosphatasia. J Bone Miner Res. 2008 Jun;23(6):775-6. doi: 10.1359/jbmr.080305. PMID: 18318644.
* Whyte MP. Hypophosphatasia - aetiology, nosology, pathogenesis, diagnosis and treatment. Nat Rev Endocrinol. 2016 Apr;12(4):233-46. doi: 10.1038/nrendo.2016.14. Epub 2016 Feb 19. PMID: 26893260.
* Whyte MP, Simmons JH, Moseley S, Fujita KP, Bishop N, Salman NJ, Taylor J, Phillips D, McGinn M, McAlister WH. Asfotase alfa for infants and young children with hypophosphatasia: 7 year outcomes of a single-arm, open-label, phase 2 extension trial. Lancet Diabetes Endocrinol. 2019 Feb;7(2):93-105. doi: 10.1016/S2213-8587(18)30307-3. Epub 2018 Dec 14. PMID: 30558909.
* Kishnani PS, Rockman-Greenberg C, Rauch F, Bhatti MT, Moseley S, Denker AE, Watsky E, Whyte MP. Five-year efficacy and safety of asfotase alfa therapy for adults and adolescents with hypophosphatasia. Bone. 2019 Apr;121:149-162. doi: 10.1016/j.bone.2018.12.011. Epub 2018 Dec 18. PMID: 30576866.
* Komaru K, Ishida-Okumura Y, Numa-Kinjoh N, Hasegawa T, Oda K. Molecular and cellular basis of hypophosphatasia. J Oral Biosci. 2019 Sep;61(3):141-148. doi: 10.1016/j.job.2019.07.003. Epub 2019 Aug 8. PMID: 31400546.
* Tobias JH, Brunetti G. Editorial: Insights in bone research 2021. Front Endocrinol (Lausanne). 2022;13:979276. doi: 10.3389/fendo.2022.979276. Epub 2022 Jul 26. PMID: 35957823; PMCID: PMC9362978.
* Riancho JA. Diagnostic Approach to Patients with Low Serum Alkaline Phosphatase. Calcif Tissue Int. 2023 Mar;112(3):289-296. doi: 10.1007/s00223-022-01039-y. Epub 2022 Nov 8. PMID: 36348061.
* Rush E, Brandi ML, Khan A, Ali DS, Al-Alwani H, Almonaei K, Alsarraf F, Bacrot S, Dahir KM, Dandurand K, Deal C, Ferrari SL, Giusti F, Guyatt G, Hatcher E, Ing SW, Javaid MK, Khan S, Kocijan R, Lewiecki EM, Linglart A, M'Hiri I, Marini F, Nunes ME, Rockman-Greenberg C, Roux C, Seefried L, Starling SR, Ward L, Yao L, Brignardello-Petersen R, Simmons JH. Proposed diagnostic criteria for the diagnosis of hypophosphatasia in children and adolescents: results from the HPP International Working Group. Osteoporos Int. 2024 Jan;35(1):1-10. doi: 10.1007/s00198-023-06843-2. Epub 2023 Nov 20. PMID: 37982855; PMCID: PMC10786745.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.